Veer Bhavnagri
Equibles does not estimate personal net worth.
Get an email with a short summary when Allogene Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get ALLO alertsAbout Veer Bhavnagri
The proxy statement of Allogene Therapeutics, Inc. reports total compensation of $4,066,186 for Veer Bhavnagri in fiscal 2022, including a base salary of $480,000. Disclosed compensation is on record for 3 fiscal years. Allogene Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Allogene Therapeutics, Inc. includes Zachary Roberts, M.D., Ph.D. (CEO and Board Member), Geoffrey Parker (CFO), Tim Moore (CTO) and 5 others.
Affiliation history
-
Allogene Therapeutics, Inc. (ALLO)
Proxy statement
Current
Company network
Leadership on record at Allogene Therapeutics, Inc.
- Zachary Roberts, M.D., Ph.D. CEO, Board Member
- Geoffrey Parker CFO
- Tim Moore CTO
- Timothy Moore CTO
- Annie Yoshiyama Chief Accounting Officer
- Elizabeth Barrett Board Member
- Stephen Mayo, Ph.D. Board Member
- Vicki Sato, Ph.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Allogene Therapeutics, Inc. (ALLO) | Former General Counsel | $480,000 | $4,066,186 |
| 2021 | Allogene Therapeutics, Inc. (ALLO) | Former General Counsel | $464,000 | $3,156,474 |
| 2020 | Allogene Therapeutics, Inc. (ALLO) | Former General Counsel | $425,000 | $2,396,328 |
Recent activity
No call appearances or filed executive changes recorded yet.